Capecitabine, DNA/RNA Synthesis Inhibitor
Por um escritor misterioso
Descrição
Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.
Full article: DNA synthesis inhibitors for the treatment of gastrointestinal cancer
Capecitabine, DNA, RNA and Protein Synthesis Inhibitors
Frontiers Co-delivery of Cisplatin(IV) and Capecitabine as an Effective and Non-toxic Cancer Treatment
Why Great Mitotic Inhibitors Make Poor Cancer Drugs: Trends in Cancer
Anti-Cancer Drugs-Medicinal Chemistry
8. newer chemical entities for cancer treatment
Frontiers PARP inhibitors combined with radiotherapy: are we ready?
Fluoropyrimidine-induced toxicity and DPD deficiency.. A case report of early onset, lethal capecitabine-induced toxicity and mini review of the literature. Uridine triacetate: Efficacy and safety as an antidote. Is it accessible outside
TAS1553, a small molecule subunit interaction inhibitor of ribonucleotide reductase, exhibits antitumor activity by causing DNA replication stress
Capecitabine, C15H22FN3O6
Emerging strategies for cancer therapy by ATR inhibitors - Yano - 2023 - Cancer Science - Wiley Online Library
Chemotherapy
Capecitabine, DNA/RNA Synthesis Inhibitor
de
por adulto (o preço varia de acordo com o tamanho do grupo)
